NCT02633371View on ClinicalTrials.gov

A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

May 31, 2017

Conditions
Hyperhidrosis
Interventions
DRUG

Oxybutynin 3% gel

Trial Locations (1)

80045

Children's Hospital, Colorado, Aurora

All Listed Sponsors
collaborator

Society for Pediatric Dermatology

OTHER

lead

University of Colorado, Denver

OTHER

NCT02633371 - A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults | Biotech Hunter | Biotech Hunter